Vascular effects of prostacyclin: does activation of PPARδ play a role?
- 25 June 2012
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 33 (10) , 559-564
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor α/δ AgonistJournal of Biological Chemistry, 2011
- Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertensionAngiogenesis, 2010
- Regulation of peroxisome proliferator‐activated receptor‐β/δ by the APC/β‐CATENIN pathway and nonsteroidal antiinflammatory drugsMolecular Carcinogenesis, 2009
- PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosisProceedings of the National Academy of Sciences, 2008
- PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosisProceedings of the National Academy of Sciences, 2008
- The Role of PPARs in the Endothelium: Implications for Cancer TherapyPPAR Research, 2008
- Regulation of skeletal muscle PPARδ mRNA expression in twinsThe Journal of Physiology, 2007
- Transcriptional network governing the angiogenic switch in human pancreatic cancerProceedings of the National Academy of Sciences, 2007
- Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progressionProceedings of the National Academy of Sciences, 2006
- Adventures in vascular biology: a tale of two mediatorsPhilosophical Transactions of the Royal Society B: Biological Sciences, 2006